DrugDashboards
← Home
Manufacturing facility

Somerset Therapeutics Private Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
54/1, Boodihal Village Nelamangala Taluk, Bengaluru, Karnataka 562123, India (IND)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3003821988 · DUNS 677236695

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 48 drugs, 5 already in shortage. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2025-02-21
  • VAIDrug Quality Assurance2023-10-27
  • OAIDrug Quality Assurance2022-04-04
  • OAIDrug Quality Assurance2020-02-19
  • VAIDrug Quality Assurance2019-07-23
  • VAIDrug Quality Assurance2017-12-05
  • NAIDrug Quality Assurance2017-04-24
  • VAIDrug Quality Assurance2013-08-20
  • OAIDrug Quality Assurance2011-09-20
  • VAIDrug Quality Assurance2009-03-31

Drugs this plant is listed as making

48 distinct drugs across 113 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.